Natural variation in avenin epitopes among oat varieties: Implications for celiac disease

Journal of Cereal Science

Volumn 54, Issue 1, 2011, Pages 8-12

  Mujico, Jorge R ^a   Mitea, Cristina ^a   Gilissen, Luud J W J ^b   de Ru, Arnoud ^a   van Veelen, Peter ^a   Smulders, Marinus J M ^b   Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Avenin epitopes; Celiac disease; Oat varieties; T cell line

Indexed keywords

AVENA; HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 79960707228     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2010.09.007     Document Type: Article

References (29)

1. Arentz-Hansen H., Fleckenstein B., Molberg O., Scott H., Koning F., Jung G., Roepstorff P., Lundin K.E., Sollid L.M. The molecular basis for oat intolerance in patients with celiac disease. PLoS Medicine 2004, 1:e1.
2. Folk J.E., Chung S.I. Transglutaminases. Methods in Enzymology 1985, 113:358-375.
3. Garcia E., Llorente M., Hernando A., Kieffer R., Wieser H., Mendez E. Development of a general procedure for complete extraction of gliadins for heat processed and unheated foods. European Journal of Gastroenterology & Hepatology 2005, 17:529-539.
4. Green P.H. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005, 128:S74-S78.
5. Hernando A., Mujico J.R., Mena M.C., Lombardia M., Mendez E. Measurement of wheat gluten and barley hordeins in contaminated oats from Europe, the United States and Canada by Sandwich R5 ELISA. European Journal of Gastroenterology & Hepatology 2008, 20:545-554.
6. Kemppainen T.A., Heikkinen M.T., Ristikankare M.K., Kosma V.M., Sontag-Strohm T.S., Brinck O., Salovaara H.O., Julkunen R.J. Unkilned and large amounts of oats in the coeliac disease diet: a randomized, controlled study. Scandinavian Journal of Gastroenterology 2008, 43:1094-1101.
7. Koskinen O., Villanen M., Korponay-Szabo I., Lindfors K., Maki M., Kaukinen K. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:559-565.
8. Lundin K.E., Nilsen E.M., Scott H.G., Loberg E.M., Gjoen A., Bratlie J., Skar V., Mendez E., Lovik A., Kett K. Oats induced villous atrophy in coeliac disease. Gut 2003, 52:1649-1652.
9. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., Thorsby E., Sollid L.M. Gliadin-specific, HLA-DQ (alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. Journal of Experimental Medicine 1993, 178:187-196.
10. Maki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., Ilonen J., Laurila K., Dahlbom I., Hansson T., Hopfl P., Knip M. Prevalence of Celiac disease among children in Finland. New England Journal of Medicine 2003, 348:2517-2524.
11. Mearin M.L., Koninckx C.R., Biemond I., Polanco I., Pena A.S. Influence of genetic factors on the serum levels of antigliadin antibodies in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 1984, 3:373-377.
12. Mitea C., Havenaar R., Drijfhout J.W., Edens L., Dekking L., Koning F. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 2008, 57:25-32.
13. Mitea C., Kooy-Winkelaar Y., van Veelen P., de Ru A., Drijfhout J.W., Koning F., Dekking L. Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome. American Journal of Clinical Nutrition 2008, 88:1057-1066.
14. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Noren O., Roepstorff P., Lundin K.E., Sjostrom H., Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 1998, 4:713-717.
15. Pulido O.M., Gillespie Z., Zarkadas M., Dubois S., Vavasour E., Rashid M., Switzer C., Godefroy S.B. Introduction of oats in the diet of individuals with celiac disease: a systematic review. Advances in Food and Nutrition Research 2009, 57:235-285.
16. Salentijn E.M., Goryunova S.V., Bas N., van der Meer I.M., van den Broeck H.C., Bastien T., Gilissen L.J., Smulders M.J. Tetraploid and hexaploid wheat varieties reveal large differences in expression of alpha-gliadins from homoeologous Gli-2 loci. BMC Genomics 2009, 10:48.
17. Silano M., Dessi M., De Vincenzi M., Cornell H. In vitro tests indicate that certain varieties of oats may be harmful to patients with coeliac disease. Journal of Gastroenterology and Hepatology 2007, 22:528-531.
18. Silano M., Di Benedetto R., Maialetti F., De Vincenzi A., Calcaterra R., Cornell H.J., De Vincenzi M. Avenins from different cultivars of oats elicit response by coeliac peripheral lymphocytes. Scandinavian Journal of Gastroenterology 2007, 42:1302-1305.
19. Sollid L.M., Markussen G., Ek J., Gjerde H., Vartdal F., Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. Journal of Experimental Medicine 1989, 169:345-350.
20. Spaenij-Dekking E.H., Kooy-Winkelaar E.M., Nieuwenhuizen W.F., Drijfhout J.W., Koning F. A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin. Gut 2004, 53:1267-1273.
21. Spaenij-Dekking L., Kooy-Winkelaar Y., van Veelen P., Drijfhout J.W., Jonker H., van Soest L., Smulders M.J., Bosch D., Gilissen L.J., Koning F. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005, 129:797-806.
22. Stepniak D., Vader L.W., Kooy Y., van Veelen P.A., Moustakas A., Papandreou N.A., Eliopoulos E., Drijfhout J.W., Papadopoulos G.K., Koning F. T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics 2005, 57:8-15.
23. Stepniak D., Wiesner M., de Ru A.H., Moustakas A.K., Drijfhout J.W., Papadopoulos G.K., van Veelen P.A., Koning F. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. Journal of Immunology 2008, 180:3268-3278.
24. Vader L.W., Stepniak D.T., Bunnik E.M., Kooy Y.M., de Haan W., Drijfhout J.W., Van Veelen P.A., Koning F. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003, 125:1105-1113.
25. Vader W., Stepniak D., Kooy Y., Mearin L., Thompson A., van Rood J.J., Spaenij L., Koning F. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proceedings of the National Academy of Sciences USA 2003, 100:12390-12395.
26. Van den Broeck H., Hongbing C., Lacaze X., Dusautoir J.-C., Gilissen L., Smulders M., van der Meer I. In search of tetraploid wheat accessions reduced in celiac disease-related gluten epitopes. Molecular BioSystems 2010, 6:2206-2213.
27. Van den Broeck H.C., de Jong H.C., Salentijn E.M.J., Dekking L., Bosch D., Hamer R.J., Gilissen L.J.W.J., van der Meer I.M., Smulders M.J.M. Presence of celiac disease epitopes in modern and old hexaploid wheat varieties. Wheat breeding may have contributed to increased prevalence of celiac disease. Theoretical and Applied Genetics 2010, 121:1527-1539.
28. van de Wal Y., Kooy Y., van Veelen P., Pena S., Mearin L., Papadopoulos G., Koning F. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. Journal of Immunology 1998, 161:1585-1588.
29. van Herpen T.W., Goryunova S.V., van der Schoot J., Mitreva M., Salentijn E., Vorst O., Schenk M.F., van Veelen P.A., Koning F., van Soest L.J., Vosman B., Bosch D., Hamer R.J., Gilissen L.J., Smulders M.J. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics 2006, 7:1.